0
0
0
FREED of Opioids Act
3/13/2024, 5:16 PM
Summary of Bill S 2737
The FREED of Opioids Act, also known as Bill 118 s 2737, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to address the opioid crisis in the United States by implementing various measures to combat the misuse and overprescription of opioids.
One key provision of the FREED of Opioids Act is the establishment of a national prescription drug monitoring program. This program would require healthcare providers to check a centralized database before prescribing opioids to ensure that patients are not receiving multiple prescriptions from different doctors, a practice known as "doctor shopping."
Additionally, the bill includes provisions to increase funding for addiction treatment and recovery programs, as well as for law enforcement efforts to combat the illegal distribution of opioids. It also aims to improve access to non-opioid pain management alternatives for patients. Overall, the FREED of Opioids Act seeks to address the opioid crisis from multiple angles, including prevention, treatment, and enforcement. Supporters of the bill argue that it is a comprehensive approach to tackling this complex issue, while critics may raise concerns about the potential impact on healthcare providers and patients.
One key provision of the FREED of Opioids Act is the establishment of a national prescription drug monitoring program. This program would require healthcare providers to check a centralized database before prescribing opioids to ensure that patients are not receiving multiple prescriptions from different doctors, a practice known as "doctor shopping."
Additionally, the bill includes provisions to increase funding for addiction treatment and recovery programs, as well as for law enforcement efforts to combat the illegal distribution of opioids. It also aims to improve access to non-opioid pain management alternatives for patients. Overall, the FREED of Opioids Act seeks to address the opioid crisis from multiple angles, including prevention, treatment, and enforcement. Supporters of the bill argue that it is a comprehensive approach to tackling this complex issue, while critics may raise concerns about the potential impact on healthcare providers and patients.
Congressional Summary of S 2737
FDA Review of Efficacy of EERW Double-Blinds of Opioids Act or the FREED of Opioids Act
This bill requires the Food and Drug Administration (FDA) to take certain actions to determine whether to permit the use of a certain methodology for drug clinical trials.
Specifically, the FDA must seek to contract with the National Academy of Sciences (NAS) for the NAS to conduct a study on the effectiveness of using enriched enrollment randomized withdrawal methodology in demonstrating the efficacy of opioid drugs in treating chronic pain.
The FDA must also convene a meeting of two specified FDA advisory committees to review the NAS study, vote on whether to permit the use of this methodology in drug clinical trials, and review the appropriateness of labeling on approved opioid drugs in relation to this methodology.
Read the Full Bill
Current Status of Bill S 2737
Bill S 2737 is currently in the status of Bill Introduced since September 7, 2023. Bill S 2737 was introduced during Congress 118 and was introduced to the Senate on September 7, 2023. Bill S 2737's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of September 7, 2023
Bipartisan Support of Bill S 2737
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
2Democrat Cosponsors
0Republican Cosponsors
2Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 2737
Primary Policy Focus
HealthAlternate Title(s) of Bill S 2737
FREED of Opioids Act
FREED of Opioids Act
FDA Review of Efficacy of EERW Double-Blinds of Opioids Act
A bill to require the Food and Drug Administration to determine whether to permit the use of enriched enrollment randomized withdrawal methodology with respect to clinical trials.
Comments
Sponsors and Cosponsors of S 2737
Latest Bills
Deport the Terrorists Act of 2026
Bill HR 9096June 6, 2026
PANA Act of 2026
Bill HR 9039June 6, 2026
To prohibit the use of Federal funds to install permanent fencing around the United States Supreme Court Building or grounds.
Bill HR 9038June 6, 2026
To amend the Federal Election Campaign Act of 1971 to make it a felony offense for any person who is seeking to be a candidate in an election for Federal office or an employee or agent of such a person to knowingly fraudulently sign any materials or documentation required to be filed as a condition of ballot access for such election, and for other purposes.
Bill HR 8977June 6, 2026
To amend the Higher Education Act of 1965 to provide enhanced student loan relief to educators, and for other purposes.
Bill HR 8896June 6, 2026
To direct the Administrator of the Federal Aviation Administration to improve and expand electronic filing capabilities for Federal Aviation Administration Form 337, and for other purposes.
Bill HR 9037June 6, 2026
To amend the Higher Education Act of 1965 to promote comprehensive campus mental health and suicide prevention plans, and for other purposes.
Bill HR 8978June 6, 2026
To direct the Secretary of State to advocate for the inclusion and recognition of the Central Tibetan Administration, and for other purposes.
Bill HR 8982June 6, 2026
To amend the Fair Labor Standards Act of 1938 to require employers to compensate employees working on a legal public holiday for such work at a rate that is not less than one and one-half times the regular rate at which the employee is employed, and for other purposes.
Bill HR 8980June 6, 2026
National Police Athletic/Activities League Youth Enrichment Reauthorization Act
Bill HR 9059June 6, 2026
SUPPORT for Patients and Communities Reauthorization Act
Bill S 3393March 5, 2024